Page last updated: 2024-08-24

mci-196 and Body Weight

mci-196 has been researched along with Body Weight in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kadonosono, K; Muraoka, T; Ogihara, K; Terauchi, Y; Utsunomiya, H; Yamakawa, T1
Awata, T; Hosaka, T; Inukai, K; Katayama, S; Kurihara, S; Nakamoto, H; Neda, T; Ono, H1
Kanai, S; Miyashita, Y; Oyama, T; Sasaki, H; Shirai, K1
Babaya, N; Fujisawa, T; Hiromine, Y; Ikegami, H; Itoi-Babaya, M; Kawabata, Y; Kobayashi, M; Nojima, K; Noso, S; Ogihara, T; Shibata, M; Yamaji, K1
Futami-Suda, S; Igari, Y; Kigawa, Y; Matsumura, N; Nakano, H; Oba, K; Ouchi, M; Suzuki, K; Suzuki, T; Watanabe, K1
Inoue, M; Koike, K; Murakami, K; Nozaki, N; Sugiura, K1

Trials

2 trial(s) available for mci-196 and Body Weight

ArticleYear
Hypoglycemic effects of colestimide on type 2 diabetic patients with obesity.
    Endocrine journal, 2012, Volume: 59, Issue:3

    Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Humans; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Male; Middle Aged; Obesity; Pilot Projects; Resins, Synthetic; Treatment Outcome

2012
Colestilan, a new bile acid-sequestering resin, reduces bodyweight in postmenopausal women who have dieted unsuccessfully.
    Drugs in R&D, 2005, Volume: 6, Issue:5

    Topics: Appetite Depressants; Bile Acids and Salts; Body Mass Index; Body Weight; Drug Administration Schedule; Eating; Female; Humans; Middle Aged; Obesity; Postmenopause; Treatment Outcome

2005

Other Studies

4 other study(ies) available for mci-196 and Body Weight

ArticleYear
Colestimide improves glycemic control via hepatic glucose production in db/db mice.
    Endocrine journal, 2014, Volume: 61, Issue:5

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Eating; Epichlorohydrin; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Liver; Mice; Mice, Inbred C57BL; Resins, Synthetic

2014
Usefulness of preheparin lipoprotein lipase mass as a parameter for predicting the efficacy of colestimide.
    Journal of atherosclerosis and thrombosis, 2005, Volume: 12, Issue:4

    Topics: Anion Exchange Resins; Body Weight; Cholesterol; Epichlorohydrin; Female; Humans; Hyperlipidemias; Imidazoles; Lipoprotein Lipase; Male; Middle Aged; Resins, Synthetic; Treatment Outcome; Triglycerides

2005
Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.
    Diabetes, 2007, Volume: 56, Issue:1

    Topics: Adipose Tissue; Animals; Anticholesteremic Agents; Blood Glucose; Body Weight; Carrier Proteins; Cholestyramine Resin; Diabetes Mellitus, Type 2; Disease Models, Animal; Epichlorohydrin; Fasting; Fatty Liver; Humans; Hyperlipidemias; Imidazoles; Insulin Resistance; Membrane Glycoproteins; Mice; Obesity; Resins, Synthetic; Weight Gain

2007
Effects of colestimide on blood glucose-lowering activity and body weight in patients with type 2 diabetes and hypercholesterolemia.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2007, Volume: 74, Issue:1

    Topics: Anion Exchange Resins; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Epichlorohydrin; Humans; Hypercholesterolemia; Imidazoles; Lipids; Resins, Synthetic

2007